Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome

Background/Aims Severe fever with thrombocytopenia syndrome (SFTS) is a viral hemorrhagic fever with a high fatality rate. However, effective treatments for SFTS cases not responded to supportive therapy have not been established. Herein, we introduced the therapeutic plasma exchange (TPE) in SFTS p...

Full description

Bibliographic Details
Main Authors: Jeong Rae Yoo, Sun Hyung Kim, Young Ree Kim, Keun Hwa Lee, Won Sup Oh, Sang Taek Heo
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2019-07-01
Series:The Korean Journal of Internal Medicine
Subjects:
Online Access:http://www.kjim.org/upload/pdf/kjim-2016-194.pdf
id doaj-72dbac3e3d5a4600b4d347275034adf3
record_format Article
spelling doaj-72dbac3e3d5a4600b4d347275034adf32021-08-10T01:10:39ZengThe Korean Association of Internal MedicineThe Korean Journal of Internal Medicine1226-33032005-66482019-07-0134490290910.3904/kjim.2016.194169942Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndromeJeong Rae Yoo0Sun Hyung Kim1Young Ree Kim2Keun Hwa Lee3Won Sup Oh4Sang Taek Heo5 Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea Department of Laboratory Medicine, Jeju National University School of Medicine, Jeju, Korea Department of Laboratory Medicine, Jeju National University School of Medicine, Jeju, Korea Department of Microbiology and Immunology, Jeju National University School of Medicine, Jeju, Korea Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea Department of Internal Medicine, Jeju National University School of Medicine, Jeju, KoreaBackground/Aims Severe fever with thrombocytopenia syndrome (SFTS) is a viral hemorrhagic fever with a high fatality rate. However, effective treatments for SFTS cases not responded to supportive therapy have not been established. Herein, we introduced the therapeutic plasma exchange (TPE) in SFTS patients in a tertiary hospital between 2013 and 2015. Methods TPE was performed in patients with rapidly progressing SFTS. Clinical, laboratory, and virological parameters were compared before and after TPE. Results Among 27 confirmed SFTS patients, two patients were treated with TPE and ribavirin combination in May 2013, then, 14 patients with rapidly progressing SFTS patients were treated with only TPE from June 2013 to September 2015: their median age was 58 years (interquartile range, 50 to 70) and eight (57.1%) were male. Body temperature, pressure-adjusted heart rate, white blood cell and platelet counts, coagulation profile, serum creatinine, and multiple organ dysfunction score improved immediately after TPE. In addition, the mean cyclic threshold value of real-time reverse transcriptase polymerase chain reaction for SFTS virus after TPE (mean ± standard deviation, 31.3 ± 2.9) was significantly higher than that before TPE (26.5 ± 2.9; p < 0.001), indicating that serum viral loads decreased after TPE. Finally, 13 of 14 TPE-treated patients (92.8%) recovered from rapidly progressing SFTS without sequelae. Conclusions SFTS patients treated with TPE showed improvements in clinical, laboratory, and virological parameters. These results suggest that TPE would be a therapeutic modality as rescue therapy in patients with rapidly progressing SFTS.http://www.kjim.org/upload/pdf/kjim-2016-194.pdfsevere fever with thrombocytopenia syndromeplasma exchangetherapeutics
collection DOAJ
language English
format Article
sources DOAJ
author Jeong Rae Yoo
Sun Hyung Kim
Young Ree Kim
Keun Hwa Lee
Won Sup Oh
Sang Taek Heo
spellingShingle Jeong Rae Yoo
Sun Hyung Kim
Young Ree Kim
Keun Hwa Lee
Won Sup Oh
Sang Taek Heo
Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome
The Korean Journal of Internal Medicine
severe fever with thrombocytopenia syndrome
plasma exchange
therapeutics
author_facet Jeong Rae Yoo
Sun Hyung Kim
Young Ree Kim
Keun Hwa Lee
Won Sup Oh
Sang Taek Heo
author_sort Jeong Rae Yoo
title Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome
title_short Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome
title_full Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome
title_fullStr Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome
title_full_unstemmed Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome
title_sort application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome
publisher The Korean Association of Internal Medicine
series The Korean Journal of Internal Medicine
issn 1226-3303
2005-6648
publishDate 2019-07-01
description Background/Aims Severe fever with thrombocytopenia syndrome (SFTS) is a viral hemorrhagic fever with a high fatality rate. However, effective treatments for SFTS cases not responded to supportive therapy have not been established. Herein, we introduced the therapeutic plasma exchange (TPE) in SFTS patients in a tertiary hospital between 2013 and 2015. Methods TPE was performed in patients with rapidly progressing SFTS. Clinical, laboratory, and virological parameters were compared before and after TPE. Results Among 27 confirmed SFTS patients, two patients were treated with TPE and ribavirin combination in May 2013, then, 14 patients with rapidly progressing SFTS patients were treated with only TPE from June 2013 to September 2015: their median age was 58 years (interquartile range, 50 to 70) and eight (57.1%) were male. Body temperature, pressure-adjusted heart rate, white blood cell and platelet counts, coagulation profile, serum creatinine, and multiple organ dysfunction score improved immediately after TPE. In addition, the mean cyclic threshold value of real-time reverse transcriptase polymerase chain reaction for SFTS virus after TPE (mean ± standard deviation, 31.3 ± 2.9) was significantly higher than that before TPE (26.5 ± 2.9; p < 0.001), indicating that serum viral loads decreased after TPE. Finally, 13 of 14 TPE-treated patients (92.8%) recovered from rapidly progressing SFTS without sequelae. Conclusions SFTS patients treated with TPE showed improvements in clinical, laboratory, and virological parameters. These results suggest that TPE would be a therapeutic modality as rescue therapy in patients with rapidly progressing SFTS.
topic severe fever with thrombocytopenia syndrome
plasma exchange
therapeutics
url http://www.kjim.org/upload/pdf/kjim-2016-194.pdf
work_keys_str_mv AT jeongraeyoo applicationoftherapeuticplasmaexchangeinpatientshavingseverefeverwiththrombocytopeniasyndrome
AT sunhyungkim applicationoftherapeuticplasmaexchangeinpatientshavingseverefeverwiththrombocytopeniasyndrome
AT youngreekim applicationoftherapeuticplasmaexchangeinpatientshavingseverefeverwiththrombocytopeniasyndrome
AT keunhwalee applicationoftherapeuticplasmaexchangeinpatientshavingseverefeverwiththrombocytopeniasyndrome
AT wonsupoh applicationoftherapeuticplasmaexchangeinpatientshavingseverefeverwiththrombocytopeniasyndrome
AT sangtaekheo applicationoftherapeuticplasmaexchangeinpatientshavingseverefeverwiththrombocytopeniasyndrome
_version_ 1721213108091879424